-
Carfilzomib Enhances Iodine-125-Induced Cell Death in ESCC
2026-06-15
This study demonstrates that Carfilzomib (PR-171), an irreversible proteasome inhibitor, markedly sensitizes esophageal squamous cell carcinoma (ESCC) cells to Iodine-125 seed radiation by aggravating endoplasmic reticulum stress. The combination therapy triggers apoptosis, paraptosis, and ferroptosis through diverse, proteasome-dependent mechanisms, highlighting new avenues for radiosensitization in ESCC research.
-
DNA Replication Controls Membrane and Vacuole Formation in E
2026-06-15
This study demonstrates that DNA replication is essential for both membrane biosynthesis and vacuole formation during the enlargement of Enterococcus faecalis protoplasts. By dissecting the specific effects of the DNA replication inhibitor novobiocin, the research clarifies how DNA replication integrates with cellular architecture and provides a comparative perspective with DNA-damaging agents such as Mitomycin C.
-
MIZ1-TMBIM4 Axis Regulates IgG1+ GC B Cell Selection via Ca2
2026-06-14
This study reveals a previously unrecognized, isotype-specific mechanism in the positive selection of germinal center (GC) B cells. By identifying the MIZ1–TMBIM4 axis as essential for the survival of IgG1+ GC B cells through regulation of BCR-mediated Ca2+ mobilization, the work provides foundational insights into humoral immunity and apoptosis signaling.
-
THZ1: Covalent CDK7 Inhibitor Workflows for T-ALL Research
2026-06-13
THZ1 enables precise, durable inhibition of CDK7-driven transcription, making it a transformative reagent in cancer biology and T-ALL research. This article delivers stepwise protocols, workflow enhancements, and troubleshooting insights to maximize the impact of THZ1 in experimental systems.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Protocols for Cancer Researc
2026-06-12
EZ Cap™ Human PTEN mRNA (ψUTP) enables robust, immune-evasive restoration of PTEN in mammalian cells, directly targeting PI3K/Akt pathway dysregulation. Its advanced Cap1 and pseudouridine modifications deliver superior mRNA stability and expression, unlocking new workflows for resistance reversal in cancer models.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Neurogen
2026-06-12
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to safeguard protein integrity during complex workflows, especially in phosphorylation-sensitive applications. Its EDTA-free formulation and broad-spectrum inhibition make it indispensable for advanced neurobiology and protein signaling studies.
-
Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi
2026-06-11
Methyl-β-cyclodextrin (SKU C6939) provides a controlled method for extracting cholesterol and select lipids from cell membranes, making it essential for studies on membrane fluidity and lipid raft organization. It should only be used in laboratory-based research workflows; diagnostic or therapeutic applications are not supported.
-
6-FAM SE: Amine-Reactive Fluorescent Dye for Molecular Label
2026-06-11
6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) is a high-stability, amine-reactive fluorescent dye for sensitive molecular labeling. Its superior hydrolytic resistance and robust amine-reactivity enable reproducible DNA, protein, and peptide labeling in demanding workflows.
-
Notch1-YY1-ICAM1 Axis Modulation Boosts HCC Immunotherapy Ef
2026-06-10
This study identifies the Notch1-YY1-ICAM1 signaling axis as a key regulator of immune escape and immunotherapy response in hepatocellular carcinoma (HCC). Targeting this pathway enhances CD8+ T cell-driven cancer cell pyroptosis, offering a promising approach to improve immunotherapeutic outcomes in advanced HCC.
-
Taltirelin Acetate: Mechanistic Insights for Neurodegenerati
2026-06-10
Discover how Taltirelin acetate, a long-acting TRH analog, drives novel neuroprotective pathways and assay strategies for Parkinson’s disease and beyond. This article deciphers new mechanistic evidence and practical protocols to advance translational neuroscience.
-
HDAC Inhibitors Repress NUT Function in NUT Carcinoma Models
2026-06-09
Shiota et al. performed a high-throughput chemical screen identifying diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT-mediated oncogenic transcription in NUT carcinoma. Their work provides mechanistic evidence for targeting HDAC activity to disrupt BRD4-NUT-driven megadomain formation, with implications for therapeutic strategies in this aggressive cancer.
-
Dissecting Pleuromutilin-Ribosome Interactions and Resistanc
2026-06-09
This article examines how pleuromutilin antibiotics and their derivatives interact with the ribosomal peptidyl transferase center, focusing on structural determinants of binding and resistance. The study’s use of chemical footprinting and ribosomal mutants provides key insights for rational antibiotic design, with implications for addressing emerging resistance.
-
CA2 Perineuronal Net Loss Drives Social Memory Deficits in A
2026-06-08
This study reveals that degradation of perineuronal nets (PNNs) in the hippocampal CA2 region is a mechanistic cause of social cognition memory loss in Alzheimer’s disease models. Experimental inhibition of matrix metalloproteinases (MMPs) preserved PNN integrity and delayed social memory impairments, highlighting the ECM–MMP axis as a promising research target.
-
Sodium Phosphate Dibasic in Aquatic Toxicity and Molecular B
2026-06-08
Sodium phosphate dibasic (Na2HPO4) is the linchpin for robust pH control in aquatic toxicity and molecular biology workflows. Its high solubility and purity empower researchers to design reproducible assays, manage complex enzyme reactions, and troubleshoot buffer instability. Discover how APExBIO’s Na2HPO4 unlocks reliable, data-driven experimentation—especially where precise pH and ionic strength are essential.
-
Dlin-MC3-DMA: Optimizing Ionizable Cationic Liposome Deliver
2026-06-07
Harness the unmatched efficiency and safety of Dlin-MC3-DMA for precise siRNA and mRNA delivery in advanced lipid nanoparticle workflows. Learn how machine learning-guided design and robust protocol optimization drive breakthroughs in gene silencing and immunomodulation.